Market Tracker

09/22 6:05pm ET

Seattle Genetics Inc (NASDAQ:SGEN)

During the Trading Day
40.03 -0.57 / -1.40%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
39.71 -0.3166 / -0.79%
 
Volume: 6.7K

Today’s Trading

Previous close40.60
Today’s open40.50
Day’s range39.20 - 40.52
Volume1,138,354
Average volume (3 months)933,967
Market cap$5.0B
Dividend yield--
Data as of 3:59pm ET, 09/22/2014

Growth & Valuation

Earnings growth (last year)-10.87%
Earnings growth (this year)-56.07%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+27.73%
P/E ratioNM
Price/Sales18.01
Price/Book21.63

Competitors

 Today’s
change
Today’s
% change
ICPTIntercept Pharmaceut...-10.81-4.19%
IDXXIDEXX Laboratories I...-2.11-1.81%
UTHRUnited Therapeutics ...+3.56+2.74%
AKRXAkorn Inc-0.41-1.11%
Data as of 3:59pm ET, 09/22/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$269.3M
Annual profit (last year)-$62.5M
Net profit margin-23.22%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer &
Secretary
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts